Carl's story: A Veteran’s experience of the benefits system

Abstract: Companion to the Sanctions, Support and Service Leavers project. "Carl's Story" is a graphic novel that illustrates the experiences of a British Armed Forces veteran named Carl as he navigates civilian life and the UK social security benefits system. ​ Based on research conducted by the University of Salford, the novel highlights the challenges veterans face, including understanding eligibility, application processes, and interactions with the Department for Work and Pensions (DWP). ​ Carl's journey reflects common issues such as employment struggles, mental health challenges like PTSD, and financial difficulties. The novel aims to shed light on the real-life experiences of veterans and the need for better support systems.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P